Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 63 for “"Drug repurposing"”.

  1. Drug Repurposing Using Gene Expression Data Mining

    <p>The conventional drug discovery process that employs the "one disease, one target, one drug'' paradigm is expensive, time-consuming, and has a high rate of failure for multi-genic complex diseases. An alternative approach to drug discovery is to repurpose an existing drug that has been used to …

    cuny-grad Repository record for Drug Repurposing Using Gene Expression Data Mining (opens in a new tab)

  2. Drug Repurposing for COVID-19 Using Molecular Docking Tools

    … mortal, finding a treatment is time critical. Drug repurposing is probably the quickest and safest approach in our arsenal. However, testing every drug in a brute force manner would require a lot of resources, and a more sophisticated method is required to filter possible candidates. Since …

    chapman Repository record for Drug Repurposing for COVID-19 Using Molecular Docking Tools (opens in a new tab)

  3. Combining Epidemiology and Biophysics in Drug Repurposing for Dementia

    [Restricted]

    cambridge

  4. Broad-spectrum antivirals against coronavirus using natural products and drug repurposing strategies

    … product-based discovery and host-targeted drug repurposing. Chapter three investigates natural product-based antiviral discovery, with a focus on Nigella sativa (black seed) oils. While direct contact assays revealed limited antiviral efficacy, vapour-phase diffusion of the oils …

    de-montfort Repository record for Broad-spectrum antivirals against coronavirus using natural products and drug repurposing strategies (opens in a new tab)

  5. Rational Identification of Neuropilin-1 Inhibitors: From Deep-Learning to Drug Repurposing

    … deep-learning-guided peptide identification and repurposing-oriented screening with validation and disease-context mapping. With this ‘proof-of-concept’ study, the work provides a basis for subsequent optimisation and for translation of NRP1-targeted inhibitors toward therapeutic development.

    cambridge Repository record for Rational Identification of Neuropilin-1 Inhibitors: From Deep-Learning to Drug Repurposing (opens in a new tab)

  6. From structural dynamics to drug repurposing: computational approaches in the context of precision medicine

    … this transition depends on the avail- ability of drugs acting on a wide variety of targets with high specificity. Within this context, G-protein coupled receptors (GPCRs) have emerged as key yet under- explored targets, with Somatostatin Receptors (SSTRs) and the Gastrin-Releasing Peptide Receptor …

    cagliari Repository record for From structural dynamics to drug repurposing: computational approaches in the context of precision medicine (opens in a new tab)

  7. Predicting drug - target interaction network using deep learning models for drug repurposing through genetic information

    … that biological and experimental methods for drug discovery are time-consuming and expensive. New efforts have been explored to perform drug repurposing through predicting drug-target interaction networks using biological and chemical properties of drugs and targets. However, due to the …

    manitoba Repository record for Predicting drug - target interaction network using deep learning models for drug repurposing through genetic information (opens in a new tab)

  8. Drug repurposing against the store-operated calcium entry (SOCE) pathway and subsequent exploration of SOCE in oligodendrocyte progenitor cells

    … conditions. In this study, the FDA-approved drug library was screened for agents that share significant similarity in 3D shape and surface electrostatics with few, hitherto best-known inhibitors of SOCE. This has led to the identification of five drugs that showed dose- dependent inhibition …

    cambridge Repository record for Drug repurposing against the store-operated calcium entry (SOCE) pathway and subsequent exploration of SOCE in oligodendrocyte progenitor cells (opens in a new tab)

  9. Drug repurposing : design, emulation and analysis of synthetic in-silico clinical trials using electronic health records and modern data analytics

    … has been limited. Even after huge investments in drug development, the need for therapeutic advances remains high. As effective anti-cancer drugs are in high demands, drug repurposing, using existing drugs for other diseases has sparked a growing interest. Drug repurposing presents a striking …

    mit Repository record for Drug repurposing : design, emulation and analysis of synthetic in-silico clinical trials using electronic health records and modern data analytics (opens in a new tab)

  10. Siderophore-Based Drug Repurposing of Platinum Anticancer Agents as Targeted Antibiotics and Investigation of Pt-Induced DNA Damage in Gram-Negative Bacteria

    … acquisition pathways for selective and efficient drug delivery as a “Trojan-horse” strategy. This thesis explores the application of a SAC strategy based on enterobactin (Ent), a native triscatecholate siderophore, to repurpose platinum (Pt) anticancer agents as targeted antibiotics against …

    mit Repository record for Siderophore-Based Drug Repurposing of Platinum Anticancer Agents as Targeted Antibiotics and Investigation of Pt-Induced DNA Damage in Gram-Negative Bacteria (opens in a new tab)

  11. Identifikace nových indikací léčiv pomocí analýzy transkriptomu jednotlivých buněk

    De novo drug development represents an exceedingly complex, time-consuming, and expensive process. Drug repurposing, utilizing large-scale transcriptomic datasets, has emerged as a promising alternative, accelerating the entire drug development pipeline. The recent introduction of single-cell RNA …

    charles-prague Repository record for Identifikace nových indikací léčiv pomocí analýzy transkriptomu jednotlivých buněk (opens in a new tab)

  12. Computational Molecular Docking Studies of Small Molecule Inhibitors With the SARS-CoV-2 Spike Protein Variants: In-Silico Drug Discovery Using Virtual Screening and Drug Repurposing Approaches

    … to develop several vaccines and treatments. Drug repurposing as a strategy for drug development has produced many of the current therapeutic options. The greatest challenge to designing a therapeutic inhibitor of SARS-CoV-2 is the shifting mutational landscape of the virus as it evolves. In …

    chapman Repository record for Computational Molecular Docking Studies of Small Molecule Inhibitors With the SARS-CoV-2 Spike Protein Variants: In-Silico Drug Discovery Using Virtual Screening and Drug Repurposing Approaches (opens in a new tab)

  13. Generating Predictive Gene Expression Signatures for Alzheimer's Disease Using Postmortem Brain Tissue

    … influence on AD pathology was assessed and drug repurposing candidates were identified using the Connectivity Map (CMAP).</p> <p><strong>Results: </strong>As a result of this analysis, predictive gene expression signatures from six AD-affected brain regions were developed with the ability to …

    chapman Repository record for Generating Predictive Gene Expression Signatures for Alzheimer's Disease Using Postmortem Brain Tissue (opens in a new tab)

  14. Exploring the network’s world: From omics-driven machine learning workflow for drug target identification to quantification of signaling model diversity.

    The drug discovery process is challenging, time-consuming, and costly, with drug target identification being an essential step in developing effective therapies. Drug repurposing offers a strategy for identifying new uses for existing drugs, aiming to simplify the process. Machine learning models …

    trento Repository record for Exploring the network’s world: From omics-driven machine learning workflow for drug target identification to quantification of signaling model diversity. (opens in a new tab)

  15. Application of foundation models for molecular representation in cancer drug discovery and precision oncology

    Drug discovery is a resource-intensive and time-consuming process, often requiring decades of effort and substantial financial investment, with a high risk of failure. Despite advances in high-throughput screening technologies, the size of chemical space presents a significant challenge: it is not …

    mit Repository record for Application of foundation models for molecular representation in cancer drug discovery and precision oncology (opens in a new tab)

  16. Causal Inference with Survival Outcomes via Orthogonal Statistical Learning

    … the effects of two first-line anti-diabetic drugs on cancer outcomes. Second, a wide range of machine learning methods (or ”learners”) for estimating heterogeneous treatment effects were not applicable to estimating effects on survival outcomes, particularly in the presence of competing …

    mit Repository record for Causal Inference with Survival Outcomes via Orthogonal Statistical Learning (opens in a new tab)

  17. In vitro and in vivo investigation of the anticancer activity and mechanism of disulfiram in malignant mesothelioma

    … options. Most often, the patients develop drug resistance due to the hypoxic tumour microenvironment (TME) that promotes the survival of chemo-resistant cancer stem cells (CSCs), leading to tumour infiltration and relapse. Drug repurposing has proven beneficial for rare orphan diseases like …

    wlv Repository record for In vitro and in vivo investigation of the anticancer activity and mechanism of disulfiram in malignant mesothelioma (opens in a new tab)

  18. Strategies to Identify Therapeutic Opportunities in the Treatment of Addictive Disorders

    … neuronal modulation, behavioral-guided therapy, drug repurposing, and combined therapeutic approaches – offer great possibilities in the development of new therapeutic approaches in the treatment of addictive disorders.

    utmb Repository record for Strategies to Identify Therapeutic Opportunities in the Treatment of Addictive Disorders (opens in a new tab)

  19. Repurposing Antibacterial Compounds and Natural Products to Combat Vancomycin-Resistant Enterococci

    … this challenge: natural product discovery and drug repurposing. The first study investigated two drug candidates, CRS3123 and ridinilazole, originally designed to target Clostridioides difficile, for their activity against VRE. Both compounds showed exceptionally low minimum inhibitory …

    vt Repository record for Repurposing Antibacterial Compounds and Natural Products to Combat Vancomycin-Resistant Enterococci (opens in a new tab)

Page 1 of 4